Logo do repositório
 
Publicação

Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure

dc.contributor.authorAugusto, Marcelo T.
dc.contributor.authorHollmann, Axel
dc.contributor.authorCastanho, Miguel A. R. B.
dc.contributor.authorPorotto, Matteo
dc.contributor.authorPessi, Antonello
dc.contributor.authorSantos, Nuno C.
dc.date.accessioned2016-04-05T16:01:16Z
dc.date.available2016-04-05T16:01:16Z
dc.date.issued2014
dc.description© The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.pt_PT
dc.description.abstractObjectives: The aim of the present work was to evaluate the interaction of two new HIV fusion inhibitors {HIVP3 [C34–polyethylene glycol (PEG)4–cholesterol] and HIVP4 [(C34–PEG4)2–cholesterol]} with membrane model systems and human blood cells in order to clarify where and how the fusion inhibitors locate, allowing us to understand their mechanism of action at the molecular level, and which strategies may be followed to increase efficacy. Methods: Lipid vesicles with defined compositions were used for peptide partition and localization studies, based on the intrinsic fluorescence of HIVP3 and HIVP4. Lipid monolayers were employed in surface pressure studies. Finally, human erythrocytes and peripheral blood mononuclear cells (PBMCs) isolated from blood samples were used in dipole potential assays. Results: Membrane partition, dipole potential and surface pressure assays indicate that the new fusion inhibitors interact preferentially with cholesterol-rich liquid-ordered membranes, mimicking biological membrane microdomains known as lipid rafts. HIVP3 and HIVP4 are able to interact with human erythrocytes and PBMCs to a similar degree as a previously described simpler drug with monomeric C34 and lacking the PEG spacer, C34–cholesterol. However, the pocket-binding domain (PBD) of both HIVP3 and HIVP4 is more exposed to the aqueous environment than in C34–cholesterol. Conclusions: The present data allow us to conclude that more efficient blocking of HIV entry results from the synergism between the membranotropic behaviour and the enhanced exposure of the PBD.pt_PT
dc.description.sponsorshipThis work was partially supported by Fundação para a Ciência e a Tecnologia—Ministério do Ensino e da Ciência (FCT-MEC, Portugal) projects PTDC/QUI-BIQ/104787/2008 and DELIN-HIVERA/0002-2013, and by National Institutes of Health (NIH, USA) project #R21NS076385 (to M. P.). A. H. also acknowledges FCT-MEC fellowship SFRH/BPD/72037/2010pt_PT
dc.identifier.citationJ Antimicrob Chemother 2014; 69: 1286 –1297pt_PT
dc.identifier.doidoi:10.1093/jac/dkt529pt_PT
dc.identifier.issn0305-7453
dc.identifier.urihttp://hdl.handle.net/10451/23254
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherOxford University Presspt_PT
dc.relationCell membrane features in HIV entry and its inhibition
dc.relation.publisherversionhttp://jac.oxfordjournals.org/pt_PT
dc.subjectHIV-1pt_PT
dc.subjectCholesterol-taggingpt_PT
dc.subjectDrug designpt_PT
dc.subjectBlood cellspt_PT
dc.titleImprovement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposurept_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardNumberPTDC/QUI-BIQ/104787/2008
oaire.awardTitleCell membrane features in HIV entry and its inhibition
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FQUI-BIQ%2F104787%2F2008/PT
oaire.citation.titleJournal of Antimicrobial Chemotherapypt_PT
oaire.citation.volumeJ Antimicrob Chemother 2014; 69: 1286–1297pt_PT
oaire.fundingStream3599-PPCDT
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isProjectOfPublicationaea345fc-1827-44ac-911d-545a3bd497a3
relation.isProjectOfPublication.latestForDiscoveryaea345fc-1827-44ac-911d-545a3bd497a3

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
Improvement_HIV.pdf
Tamanho:
251.18 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: